{
    "资产负债表": [
        {
            "date": "2018-12-31",
            "流动资产：": "",
            "货币资金": "1,327,654,747.56",
            "结算备付金": "",
            "拆出资金": "",
            "以公允价值计量且其变动计入当期损益的金融资产": "2",
            "衍生金融资产": "",
            "应收票据及应收账款": "1,546,446,540.60",
            "其中：应收票据": "60,872,266.70",
            "应收账款": "1,485,574,273.90",
            "预付款项": "225,867,963.73",
            "应收保费": "",
            "应收分保账款": "",
            "应收分保合同准备金": "",
            "其他应收款": "110,499,433.95",
            "其中：应收利息": "",
            "应收股利": "",
            "买入返售金融资产": "",
            "存货": "1,823,133,780.31",
            "持有待售资产": "",
            "一年内到期的非流动资产": "7",
            "其他流动资产": "119,087,910.00",
            "流动资产合计": "5,167,024,122.55",
            "非流动资产：": "",
            "发放贷款和垫款": "",
            "可供出售金融资产": "1,108,658,844.36",
            "持有至到期投资": "",
            "长期应收款": "",
            "长期股权投资": "291,300,571.77",
            "投资性房地产": "181,091,747.56",
            "固定资产": "2,942,396,514.38",
            "在建工程": "211,838,764.87",
            "生产性生物资产": "",
            "油气资产": "",
            "无形资产": "223,303,784.20",
            "开发支出": "",
            "商誉": "144,660,795.19",
            "长期待摊费用": "63,794,091.23",
            "递延所得税资产": "26,678,053.33",
            "其他非流动资产": "13,567,617.47",
            "非流动资产合计": "5,207,290,784.36",
            "资产总计": "10,374,314,906.91",
            "流动负债：": "",
            "短期借款": "3,316,938,450.34",
            "向中央银行借款": "",
            "吸收存款及同业存放": "",
            "拆入资金": "",
            "以公允价值计量且其变动计入当期损益的金融负债": "",
            "衍生金融负债": "",
            "应付票据及应付账款": "1,154,268,911.15",
            "预收款项": "266,967,747.48",
            "卖出回购金融资产款": "",
            "应付手续费及佣金": "",
            "应付职工薪酬": "85,224,738.12",
            "应交税费": "81,097,993.48",
            "其他应付款": "195,836,905.35",
            "其中：应付利息": "6,290,163.17",
            "应付股利": "87,018.39",
            "应付分保账款": "",
            "保险合同准备金": "",
            "代理买卖证券款": "",
            "代理承销证券款": "",
            "持有待售负债": "",
            "一年内到期的非流动负债": "",
            "其他流动负债": "",
            "流动负债合计": "5,100,334,745.92",
            "非流动负债：": "",
            "长期借款": "493,000,000.00",
            "应付债券": "",
            "其中：优先股": "",
            "永续债": "",
            "长期应付款": "",
            "长期应付职工薪酬": "",
            "预计负债": "",
            "递延收益": "41,051,146.03",
            "递延所得税负债": "35,682,193.53",
            "其他非流动负债": "",
            "非流动负债合计": "569,733,339.56",
            "负债合计": "5,670,068,085.48",
            "所有者权益（或股东权益）：": "",
            "股本": "1,516,736,158.00",
            "其他权益工具": "",
            "资本公积": "361,695,252.15",
            "减：库存股": "",
            "其他综合收益": "29",
            "专项储备": "",
            "盈余公积": "565,456,023.19",
            "一般风险准备": "",
            "未分配利润": "2,025,435,777.85",
            "归属于母公司所有者权益合计": "4,469,125,496.99",
            "少数股东权益": "235,121,324.44",
            "所有者权益（或股东权益）合计": "4,704,246,821.43",
            "负债和所有者权益（或股东权益）总计": "10,374,314,906.91"
        },
        {
            "date": "2018-1-1",
            "流动资产：": "",
            "货币资金": "1,003,996,878.71",
            "结算备付金": "",
            "拆出资金": "",
            "以公允价值计量且其变动计入当期损益的金融资产": "4,833,746.40",
            "衍生金融资产": "",
            "应收票据及应收账款": "1,478,220,323.74",
            "其中：应收票据": "74,065,331.25",
            "应收账款": "1,404,154,992.49",
            "预付款项": "223,551,136.42",
            "应收保费": "",
            "应收分保账款": "",
            "应收分保合同准备金": "",
            "其他应收款": "126,988,149.14",
            "其中：应收利息": "",
            "应收股利": "",
            "买入返售金融资产": "",
            "存货": "1,781,164,756.93",
            "持有待售资产": "",
            "一年内到期的非流动资产": "9,500,000.00",
            "其他流动资产": "92,178,947.61",
            "流动资产合计": "4,706,100,192.55",
            "非流动资产：": "",
            "发放贷款和垫款": "",
            "可供出售金融资产": "938,621,087.40",
            "持有至到期投资": "",
            "长期应收款": "",
            "长期股权投资": "316,793,897.61",
            "投资性房地产": "175,607,766.93",
            "固定资产": "3,302,936,640.78",
            "在建工程": "108,445,947.97",
            "生产性生物资产": "",
            "油气资产": "",
            "无形资产": "228,476,164.71",
            "开发支出": "",
            "商誉": "149,864,801.48",
            "长期待摊费用": "59,996,462.13",
            "递延所得税资产": "18,630,831.42",
            "其他非流动资产": "32,527,156.65",
            "非流动资产合计": "5,331,900,757.08",
            "资产总计": "10,038,000,949.63",
            "流动负债：": "",
            "短期借款": "3,337,628,529.48",
            "向中央银行借款": "",
            "吸收存款及同业存放": "",
            "拆入资金": "",
            "以公允价值计量且其变动计入当期损益的金融负债": "",
            "衍生金融负债": "",
            "应付票据及应付账款": "1,120,817,055.20",
            "预收款项": "133,672,922.02",
            "卖出回购金融资产款": "",
            "应付手续费及佣金": "",
            "应付职工薪酬": "78,496,471.07",
            "应交税费": "103,072,465.36",
            "其他应付款": "210,761,242.33",
            "其中：应付利息": "7,087,053.39",
            "应付股利": "87,018.39",
            "应付分保账款": "",
            "保险合同准备金": "",
            "代理买卖证券款": "",
            "代理承销证券款": "",
            "持有待售负债": "",
            "一年内到期的非流动负债": "",
            "其他流动负债": "",
            "流动负债合计": "4,984,448,685.46",
            "非流动负债：": "",
            "长期借款": "502,000,000.00",
            "应付债券": "",
            "其中：优先股": "",
            "永续债": "",
            "长期应付款": "",
            "长期应付职工薪酬": "",
            "预计负债": "",
            "递延收益": "40,214,625.59",
            "递延所得税负债": "7,003,778.96",
            "其他非流动负债": "",
            "非流动负债合计": "549,218,404.55",
            "负债合计": "5,533,667,090.01",
            "所有者权益（或股东权益）：": "",
            "股本": "1,516,736,158.00",
            "其他权益工具": "",
            "资本公积": "361,748,232.11",
            "减：库存股": "",
            "其他综合收益": "-197,714.20",
            "专项储备": "",
            "盈余公积": "524,315,023.98",
            "一般风险准备": "",
            "未分配利润": "1,861,344,939.62",
            "归属于母公司所有者权益合计": "4,264,144,353.71",
            "少数股东权益": "240,189,505.91",
            "所有者权益（或股东权益）合计": "4,504,333,859.62",
            "负债和所有者权益（或股东权益）总计": "10,038,000,949.63"
        }
    ],
    "利润表": [
        {
            "date": "2018-12-31",
            "一、营业总收入": "9,009,856,257.37",
            "其中：营业收入": "9,009,856,257.37",
            "利息收入": "10,522,894.47",
            "已赚保费": "",
            "手续费及佣金收入": "",
            "二、营业总成本": "8,688,919,582.36",
            "其中：营业成本": "7,310,546,242.61",
            "利息支出": "",
            "手续费及佣金支出": "",
            "退保金": "",
            "赔付支出净额": "",
            "提取保险合同准备金净额": "",
            "保单红利支出": "",
            "分保费用": "",
            "税金及附加": "81,355,450.41",
            "销售费用": "370,265,041.40",
            "管理费用": "561,984,233.20",
            "研发费用": "159,205,676.67",
            "财务费用": "174,872,664.09",
            "其中：利息费用": "181,500,679.65",
            "资产减值损失": "30,690,273.98",
            "加：其他收益": "33,688,792.31",
            "投资收益（损失以“－”号填列）": "209,350,442.40",
            "其中：对联营企业和合营企业的投资收益": "24,333,506.32",
            "公允价值变动收益（损失以“－”号填列）": "41",
            "资产处置收益（损失以“－”号填列）": "-8,886,611.49",
            "汇兑收益（损失以“－”号填列）": "",
            "三、营业利润（亏损以“－”号填列）": "554,491,264.63",
            "加：营业外收入": "6,998,050.91",
            "减：营业外支出": "9,405,127.25",
            "四、利润总额（亏损总额以“－”号填列）": "552,084,188.29",
            "减：所得税费用": "98,861,697.14",
            "五、净利润（净亏损以“－”号填列）": "453,222,491.15"
        },
        {
            "date": "2017-12-31",
            "一、营业总收入": "8,507,610,491.66",
            "其中：营业收入": "8,507,610,491.66",
            "利息收入": "7,858,281.55",
            "已赚保费": "",
            "手续费及佣金收入": "",
            "二、营业总成本": "8,211,367,362.48",
            "其中：营业成本": "6,921,622,525.36",
            "利息支出": "",
            "手续费及佣金支出": "",
            "退保金": "",
            "赔付支出净额": "",
            "提取保险合同准备金净额": "",
            "保单红利支出": "",
            "分保费用": "",
            "税金及附加": "72,488,113.46",
            "销售费用": "317,611,804.55",
            "管理费用": "541,308,596.51",
            "研发费用": "151,403,559.73",
            "财务费用": "198,199,320.12",
            "其中：利息费用": "192,292,271.01",
            "资产减值损失": "8,733,442.75",
            "加：其他收益": "25,497,277.87",
            "投资收益（损失以“－”号填列）": "441,614,784.09",
            "其中：对联营企业和合营企业的投资收益": "8,083,853.27",
            "公允价值变动收益（损失以“－”号填列）": "-598,033.60",
            "资产处置收益（损失以“－”号填列）": "-92,561,094.84",
            "汇兑收益（损失以“－”号填列）": "",
            "三、营业利润（亏损以“－”号填列）": "670,794,096.30",
            "加：营业外收入": "20,543,084.08",
            "减：营业外支出": "23,089,858.72",
            "四、利润总额（亏损总额以“－”号填列）": "668,247,321.66",
            "减：所得税费用": "97,986,867.91",
            "五、净利润（净亏损以“－”号填列）": "570,260,453.75"
        }
    ],
    "现金流量表": [
        {
            "date": "2018-12-31",
            "重新计量设定受益计划变动额": "",
            "权益法下不能转损益的其他综合收益": "",
            "（二）将重分类进损益的其他综合收益": "-197,714.20",
            "权益法下可转损益的其他综合收益": "-197,714.20",
            "可供出售金融资产公允价值变动损益": "-381,559,197.57",
            "持有至到期投资重分类为可供出售金融资产损益": "",
            "现金流量套期损益的有效部分": "",
            "外币财务报表折算差额": "",
            "其他": "",
            "六、综合收益总额": "411,212,277.87",
            "七、每股收益：": "",
            "（一）基本每股收益(元/股)": "",
            "（二）稀释每股收益(元/股)": "",
            "质押贷款净增加额": "",
            "取得子公司及其他营业单位支付的现金净额": "",
            "支付其他与投资活动有关的现金": "",
            "投资活动现金流出小计": "2,697,826,114.31",
            "投资活动产生的现金流量净额": "-210,252,911.87",
            "三、筹资活动产生的现金流量：": "",
            "吸收投资收到的现金": "15,000,000.00",
            "其中：子公司吸收少数股东投资收到的现金": "15,000,000.00",
            "取得借款收到的现金": "4,892,262,249.68",
            "发行债券收到的现金": "",
            "收到其他与筹资活动有关的现金": "46",
            "筹资活动现金流入小计": "4,892,262,249.68",
            "偿还债务支付的现金": "4,922,082,022.20",
            "分配股利、利润或偿付利息支付的现金": "421,398,231.89",
            "其中：子公司支付给少数股东的股利、利润": "11,858,546.74",
            "支付其他与筹资活动有关的现金": "13,750,000.00",
            "筹资活动现金流出小计": "5,357,230,254.09",
            "筹资活动产生的现金流量净额": "-464,968,004.41",
            "四、汇率变动对现金及现金等价物的影响": "721,355.56",
            "五、现金及现金等价物净增加额": "323,489,975.69",
            "加：期初现金及现金等价物余额": "964,235,639.28",
            "六、期末现金及现金等价物余额": "1,287,725,614.97"
        },
        {
            "date": "2017-12-31",
            "重新计量设定受益计划变动额": "",
            "权益法下不能转损益的其他综合收益": "",
            "（二）将重分类进损益的其他综合收益": "-381,559,197.57",
            "权益法下可转损益的其他综合收益": "",
            "可供出售金融资产公允价值变动损益": "",
            "持有至到期投资重分类为可供出售金融资产损益": "",
            "现金流量套期损益的有效部分": "",
            "外币财务报表折算差额": "",
            "其他": "",
            "六、综合收益总额": "45,789,349.47",
            "七、每股收益：": "",
            "（一）基本每股收益(元/股)": "",
            "（二）稀释每股收益(元/股)": "",
            "质押贷款净增加额": "",
            "取得子公司及其他营业单位支付的现金净额": "",
            "支付其他与投资活动有关的现金": "",
            "投资活动现金流出小计": "2,605,574,838.62",
            "投资活动产生的现金流量净额": "285,502,801.76",
            "三、筹资活动产生的现金流量：": "",
            "吸收投资收到的现金": "",
            "其中：子公司吸收少数股东投资收到的现金": "",
            "取得借款收到的现金": "4,346,717,321.05",
            "发行债券收到的现金": "",
            "收到其他与筹资活动有关的现金": "9,325,000.00",
            "筹资活动现金流入小计": "4,371,042,321.05",
            "偿还债务支付的现金": "2,228,855,612.53",
            "分配股利、利润或偿付利息支付的现金": "363,778,137.92",
            "其中：子公司支付给少数股东的股利、利润": "10,969,826.84",
            "支付其他与筹资活动有关的现金": "2,887,209,342.04",
            "筹资活动现金流出小计": "5,479,843,092.49",
            "筹资活动产生的现金流量净额": "-1,108,800,771.44",
            "四、汇率变动对现金及现金等价物的影响": "-6,953,841.54",
            "五、现金及现金等价物净增加额": "230,585,804.04",
            "加：期初现金及现金等价物余额": "733,649,835.24",
            "六、期末现金及现金等价物余额": "964,235,639.28"
        }
    ]
}